Page last updated: 2024-10-26

dipyridamole and Bilharziasis

dipyridamole has been researched along with Bilharziasis in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research Excerpts

ExcerptRelevanceReference
" Mice receiving the combination of tubercidin (or nebularine) plus NBMPR-P or dilazep, as well as those that survived the combination with dipyridamole, appeared healthy and were found to have normal size livers and spleens."1.27Treatment of schistosomiasis by purine nucleoside analogues in combination with nucleoside transport inhibitors. ( Cha, S; el Kouni, MH; Messier, NJ, 1987)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
el Kouni, MH1
Messier, NJ1
Cha, S1

Other Studies

1 other study available for dipyridamole and Bilharziasis

ArticleYear
Treatment of schistosomiasis by purine nucleoside analogues in combination with nucleoside transport inhibitors.
    Biochemical pharmacology, 1987, Nov-15, Volume: 36, Issue:22

    Topics: Adenosine; Animals; Biological Transport; Dilazep; Dipyridamole; Drug Therapy, Combination; Female;

1987